http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bda1e639f7277457118ecbe68d6b2139
Outgoing Links
Predicate | Object |
---|---|
family-name | Chung W. K. Chung |
name | Leland W K Chung Leland W. K. Chung |
given-name | Leland W. K. Leland W K Leland |
organization-name | Uro-oncology Research Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Department of Urology, Emory School of Medicine, Atlanta, GA 30311, USA; Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA The James Buchanan Brady Urological Institute and the Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins Hospital, Baltimore, Maryland, USA Department of Urology, Emory University, Atlanta, GA, USA; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA Department of Medicine, The Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8750 Beverly Boulevard Atrium 103, Los Angeles, California 90048, United States Department of Medicine, Uro-Oncology Research Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Uro‐Oncology Research, Department of Medicine Cedars‐Sinai Medical Center Los Angeles California Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. Leland.Chung@cshs.org. Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States Authors' Affiliations: 1Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California; 2Molecular Urology and Therapeutics and 3Division of Endocrinology and Metabolism and Lipids, Emory University School of Medicine, Atlanta, Georgia; 4Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama; and 5Atlanta Veterans Affairs Medical Center, Decatur, Georgia Department of Medicine; Uro-Oncology Research Program; Los Angeles California; Department of Surgery; Cedars-Sinai Medical Center; Los Angeles California Molecular Urology and Therapeutics Program, Department of Urology, University of Virginia, Charlottesville, VA 22908; Departments of Urology and Cell Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; and Department of Chemistry, Florida State University, Tallahassee, FL 32306 Uro-Oncology Research Program, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States Authors' Affiliations: 1Department of Urology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia; 2Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California; 3Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama; and 4Department of Urology, University of Washington School of Medicine and Department of Veterans Affairs Medical Center, Seattle, Washington; Authors' Affiliations: 1Department of Urology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia; 2Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California; 3Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama; and 4Department of Urology, University of Washington School of Medicine and Department of Veterans Affairs Medical Center, Seattle, Washington Urologic Oncology Program and Uro‐Oncology Research Laboratories, Samuel Oschin Comprehensive Cancer Institute Cedars‐Sinai Medical Center Los Angeles California Uro-Oncology Research Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, United States Emory University School of Medicine (L.W.K.C.), Atlanta, Georgia 30322; 1Molecular Urology and Therapeutics, Department of Urology, Uro-Oncology Research Program, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA Department of Urology and Winship Cancer Institute, Emory University |
Incoming Links
Total number of triples: 140.